{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T07:53:27Z","timestamp":1717487607865},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jhep.2013.06.003","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T22:02:25Z","timestamp":1371160945000},"page":"1139-1142","source":"Crossref","is-referenced-by-count":11,"title":["Severe immune-mediated drug-induced liver injury linked to ibandronate: A case report"],"prefix":"10.1016","volume":"59","author":[{"given":"Nicolas","family":"Goossens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Spahr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rubbia-Brandt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2013.06.003_b0005","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.2174\/138161210793563617","article-title":"Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition","volume":"16","author":"Dunford","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jhep.2013.06.003_b0010","first-page":"488","article-title":"Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study","volume":"35","author":"Eisman","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1185\/030079905X30752","article-title":"Ibandronate produces significant, similar antifracture efficacy in North American and European women: new clinical findings from bone","volume":"21","author":"Chesnut","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jhep.2013.06.003_b0020","first-page":"179","article-title":"Severe acute hepatitis induced by alendronate","volume":"26","author":"Carrere","year":"2002","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.jhep.2013.06.003_b0140","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0210-5705(01)70164-1","article-title":"Alendronate-induced hepatocellular lesion","volume":"24","author":"de La Serna Higuera","year":"2001","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1056\/NEJM200008033430512","article-title":"Liver damage due to alendronate","volume":"343","author":"Halabe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2013.06.003_b0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s001980050205","article-title":"Clodronate as a cause of aminotransferase elevation","volume":"10","author":"Laitinen","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jhep.2013.06.003_b0040","first-page":"271","article-title":"Hepatitis after alendronate","volume":"53","author":"Lieverse","year":"1998","journal-title":"Neth J Med"},{"key":"10.1016\/j.jhep.2013.06.003_b0045","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2006.04.032","article-title":"Risedronate-induced hepatitis","volume":"120","author":"Phillips","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2013.06.003_b0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s00198-010-1230-5","article-title":"Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget\u2019s disease of bone","volume":"22","author":"Polyzos","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jhep.2013.06.003_b0055","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00198-007-0323-2","article-title":"Hepatotoxicity induced by alendronate therapy","volume":"18","author":"Yanik","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.jhep.2013.06.003_b0060","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2013.06.003_b0065","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2013II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jhep.2013.06.003_b0070","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/hep.510260319","article-title":"Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis","volume":"26","author":"Maria","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2013.06.003_b0075","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2007.05.001","article-title":"Transjugular liver biopsy \u2013 indications, adequacy, quality of specimens, and complications \u2013 a systematic review","volume":"47","author":"Kalambokis","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0080","first-page":"603","article-title":"Transjugular liver biopsy in the 1990s: a 2-year audit","volume":"1999","author":"Papatheodoridis","year":"1990","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2013.06.003_b0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9343(80)90378-2","article-title":"The spectrum of liver disease in systemic lupus erythematosus. Report of 33 histologically-proved cases and review of the literature","volume":"69","author":"Runyon","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.jhep.2013.06.003_b0090","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2010.06.046","article-title":"Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis","volume":"139","author":"Manns","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2013.06.003_b0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00042737-200012030-00017","article-title":"Ursodeoxycholic acid (UDCA) for the treatment of amoxycillin-clavulanate potassium (Augmentin)-induced intra-hepatic cholestasis: report of two cases","volume":"12","author":"Katsinelos","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","volume":"84","author":"Wree","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2013.06.003_b0105","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/0190-9622(92)70090-3","article-title":"High-dose hydroxychloroquine treatment of porphyria cutanea tarda","volume":"26","author":"Petersen","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0110","first-page":"1896","article-title":"Safety and efficacy of hydroxychloroquine as maintenance therapy for rheumatoid arthritis after combination therapy with methotrexate and hydroxychloroquine","volume":"24","author":"Clegg","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0115","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1258\/0004563054890105","article-title":"Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe","volume":"42","author":"van Heyningen","year":"2005","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/j.jhep.2013.06.003_b0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2011.07.023","article-title":"Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing","volume":"56","author":"Bjornsson","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0125","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0130","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2011.02.024","article-title":"Drug induced liver injury and its relationship to autoimmune hepatitis","volume":"55","author":"Weiler-Normann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2013.06.003_b0135","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/hep.23588","article-title":"Drug-induced autoimmune hepatitis: clinical characteristics and prognosis","volume":"51","author":"Bjornsson","year":"2010","journal-title":"Hepatology"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813003814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827813003814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T04:52:30Z","timestamp":1539579150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827813003814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0168827813003814"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2013.06.003","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}